All Articles — MEF2C News

MEF2C and the Developing Brain

Between 2012 and 2014, multiple research groups revealed how losing one copy of MEF2C causes such profound neurological damage.

2026-06-09

Research

MEF2C Regulates Both Early Development and Late-Life Brain Health

Two recent studies, seemingly unrelated at first glance, offer profound new insights into the gene MEF2C, shedding light on its roles in heart development, brain immunity, and the consequences for individuals with MEF2C Haploinsufficiency Syndrome (MCHS).

2026-06-09

Foundation News

From Sydney to New York: MEF2C Foundation Australia Leads the Global Charge

MEF2C Foundation Australia is at the frontline of the Volare Study, the first longitudinal natural history study for MCHS.

2026-06-09

Foundation News

Milestone Numbers: US MEF2C Foundation Registry Reaches 170 Patients

The US MEF2C Foundation has reached a critical data threshold, with 170 patients now registered in the foundation's registry. This growing longitudinal dataset is fueling the path toward human clinical trials for MEF2C Haploinsufficiency Syndrome.

2026-06-08

Foundation News

Pathways to Hope: MEF2C Foundation UK Surpasses £400K Target

The MEF2C Foundation UK has shattered its fundraising goal during Rare Disease Day 2026, raising over half a million pounds to fund critical clinical trial milestones.

2026-06-07

Historical

Finding a Name for the Unnameable: The Emergence of MEF2C Haploinsufficiency Syndrome

For countless families, the journey for their child struggling with unexplained developmental delays, epilepsy, or severe movement impairment often reached a critical point: moving from a world of frustration with "we don't know" to a moment of nascent hope with "now we have a name."

2026-06-01